| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1023582M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0123582 |
| P932 | PMC publication ID | 4390320 |
| P698 | PubMed publication ID | 25853482 |
| P5875 | ResearchGate publication ID | 274727285 |
| P50 | author | Arthur Kavanaugh | Q93106996 |
| P2093 | author name string | Glenn Haugeberg | |
| Tuulikki Sokka | |||
| Andreas P Diamantopoulos | |||
| Brigitte Michelsen | |||
| Dag Magnar Soldal | |||
| Inger Johanne W Hansen | |||
| Ragnhild Fiane | |||
| P2860 | cites work | Methotrexate for ankylosing spondylitis | Q24200564 |
| Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score | Q24817087 | ||
| Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis | Q27693878 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index | Q28299001 | ||
| Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics | Q30589532 | ||
| Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors | Q31038425 | ||
| A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional he | Q33293243 | ||
| A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort | Q33760824 | ||
| Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis | Q34192955 | ||
| Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review | Q34244819 | ||
| A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index | Q34307327 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| Psoriatic arthritis: epidemiology, clinical features, course, and outcome | Q35579437 | ||
| Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7. | Q36304492 | ||
| The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people | Q37172521 | ||
| Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study | Q37267600 | ||
| Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. | Q37442945 | ||
| Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force | Q37465518 | ||
| Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis | Q37672346 | ||
| Evidence for treating rheumatoid arthritis to target: results of a systematic literature search | Q37710906 | ||
| Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future | Q37882064 | ||
| European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | Q37939700 | ||
| Spondyloarthritides | Q37977674 | ||
| Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis | Q38002841 | ||
| First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis | Q38003531 | ||
| Tobacco and other environmental risk factors in rheumatoid arthritis. | Q38011489 | ||
| Pathogenetic overview of psoriatic disease | Q38023161 | ||
| How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy | Q38120199 | ||
| Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis | Q38176549 | ||
| Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. | Q46016837 | ||
| Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. | Q50118941 | ||
| Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. | Q50661137 | ||
| Incidence and prevalence of ankylosing spondylitis in Northern Norway. | Q50774004 | ||
| The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. | Q51848130 | ||
| The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. | Q52911182 | ||
| Ankylosing spondylitis | Q54165668 | ||
| Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. | Q54436126 | ||
| Rheumatoid arthritis | Q56656479 | ||
| Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire | Q71095022 | ||
| Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis | Q73810982 | ||
| Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis | Q73899187 | ||
| Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority | Q74714748 | ||
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
| The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis | Q80713200 | ||
| Differences in body mass index among individuals with PsA, psoriasis, RA and the general population | Q82696202 | ||
| Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity | Q84586924 | ||
| Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis | Q84972080 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| psoriatic arthritis | Q511097 | ||
| P304 | page(s) | e0123582 | |
| P577 | publication date | 2015-04-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis | |
| P478 | volume | 10 |
| Q90664422 | A Review for Physician Assistants and Nurse Practitioners on the Considerations for Diagnosing and Treating Psoriatic Arthritis |
| Q90140940 | Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries |
| Q59335170 | DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs |
| Q92464789 | Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry |
| Q58574649 | Effect of high-intensity interval training on cardiovascular disease risk factors and body composition in psoriatic arthritis: a randomised controlled trial |
| Q38661777 | European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update |
| Q42081434 | Identification of dysregulated genes in rheumatoid arthritis based on bioinformatics analysis |
| Q28071252 | Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools |
| Q92737255 | Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study |
| Q47130206 | MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites |
| Q90173183 | Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice |
| Q40054186 | Management of patients with inflammatory bowel disease and spondyloarthritis |
| Q90299559 | Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population |
| Q42365374 | Patient Burden of Axial Spondyloarthritis |
| Q39530149 | Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis |
| Q35755789 | Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care |
| Q55195946 | Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study. |
| Q93103600 | Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study |
| Q94348338 | Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases |
| Q37296364 | Surgery for lumbar spinal stenosis in patients with rheumatoid arthritis: A multicenter observational study |
| Q57171084 | Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway |
| Q92197666 | The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies |
| Q64984148 | The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values. |
| Q30397234 | The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis |
Search more.